Samsung Biologics news

About

Samsung Biologics Co., Ltd. (Korean: 삼성바이오로직스) is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.

Source: Wikipedia (CC BY-SA)

On coda.news

1 event, reported by media in 1 country

Latest news

technology1 d ago

Samsung Biologics showcases its biopharmaceutical manufacturing technology at BPI 2026 in Boston

According to The Korea Times Business, Samsung Biologics showcased its biopharmaceutical manufacturing technologies at BioProcess International 2026 in Boston, presenting an integrated chemistry, manufacturing and controls strategy and the S-Tensify cell-culture platform, and highlighting its participation in BPI from Sept. 22–25 and its presence at Cell & Gene Therapy International. The event drew more than 3,000 biopharmaceutical professionals, and Samsung Biologics emphasized its capabilities across contract research, development and manufacturing. Abigail Garcia and James Choi were among the presenters, with Choi noting the company’s ongoing efforts to strengthen its global position in biopharmaceutical development.

Similar companies

Samsung Biologics showcases its biopharmaceutical manufacturing technology at BPI 2026 in Boston

technology1 d ago

coda.news AI summary

BPI 2026 was held in Boston from Sept. 22–25, and Samsung Biologics had a booth and participated in multiple presentations.
The event attracted more than 3,000 professionals from the biopharmaceutical sector.
The S-Tensify cell-culture scale-up platform can increase cell density and deliver up to a twofold increase in yield while maintaining quality.
Abigail Garcia and James Choi presented analyses and showcased the company’s capabilities and positioning in the global biopharmaceutical development market.

Samsung Biologics

The Korea Times BusinessRead original ↗